Keywords: strong, ph, iia, data, octoplus, locteron, belgian

Strong Ph IIa data for OctoPlus' Locteron

Article | 30 July 2007

Print This

Belgian drug delivery and development firm OctoPlus NV has reported positive initial results from an ongoing SELECT-1 Phase IIa study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in